Manchin-Schumer plan would increase medicine costs while killing innovation

Published




Among the many wrongheaded features of the Manchin-Schumer tax-and-spendathon bill being pushed in Congress right now, the one on prescription drug pricing is a deadly vampire of a proposal that, for 16 years, has refused to stay deceased.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.